# Nef and Vpu: Broad-Spectrum Modulators of Cell Surface Receptors

**ID:** MOL-009
**Year:** 2015 (with 2024 updates)
**Journal:** Journal of Virology
**DOI:** [10.1128/JVI.02333-14](https://journals.asm.org/doi/10.1128/jvi.02333-14)

---

## Abstract

HIV-1 Nef and Vpu function as broad-spectrum modulators of cell surface receptors, targeting far more proteins than previously appreciated. Beyond their canonical targets (CD4, MHC-I, tetherin), these accessory proteins downregulate tetraspanins, adhesion molecules, and immune receptors. This comprehensive remodeling of the cell surface creates an environment optimized for viral replication, immune evasion, and virion release.

---

## Key Concepts

- **Cell Surface Remodeling**: Coordinated downregulation of multiple receptor classes
- **Tetraspanins**: Membrane-organizing proteins targeted by Nef/Vpu
- **Immune Receptor Modulation**: Beyond MHC—targeting NK cell ligands
- **Trafficking Hijacking**: Redirection of endocytic and secretory pathways

---

## Nef Target Repertoire

### Classical Targets
| Target | Mechanism | Functional Consequence |
|:-------|:----------|:-----------------------|
| CD4 | Endocytosis + lysosomal degradation | Prevent superinfection |
| MHC-I (HLA-A, HLA-B) | AP-1/AP-2 mediated | CTL evasion |
| CD28 | Downregulation | Impaired T cell costimulation |
| CXCR4 | Surface reduction | Altered tropism |

### Expanded Targets (2018+ Research)
| Target Class | Specific Proteins | Impact |
|:-------------|:------------------|:-------|
| Tetraspanins | CD81, CD82, CD63 | Altered membrane organization |
| Adhesion molecules | ICAM-1, LFA-1 | Reduced immune synapse |
| Cytokine receptors | IL-2Rα | Impaired T cell proliferation |
| NK cell ligands | MICA, MICB | NK cell evasion |

> "The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4+ T cells."

---

## Vpu Target Repertoire

### Primary Targets
| Target | Mechanism | Functional Consequence |
|:-------|:----------|:-----------------------|
| **Tetherin (BST-2)** | βTrCP-mediated ubiquitination | Enhanced virion release |
| **CD4** | ER retention + ERAD | Prevent Env binding |
| **NTB-A** | Downregulation | NK cell evasion |

### Broader Targets
| Target | Consequence |
|:-------|:------------|
| PVR (CD155) | Altered NK cell recognition |
| Nectin-2 (CD112) | Immune synapse disruption |
| CCR7 | Impaired T cell homing |

---

## Mechanisms of Surface Receptor Modulation

### Nef Trafficking Pathways
```
Nef binds target receptor cytoplasmic tail →
Recruits AP-1 or AP-2 adaptor complexes →
Clathrin-mediated endocytosis →
Lysosomal targeting and degradation
```

### Vpu Degradation Pathway
```
Vpu binds target in ER/Golgi →
Recruits βTrCP E3 ligase →
Ubiquitination of target →
ERAD or lysosomal degradation
```

---

## Tetraspanin Targeting

### Tetraspanin Functions in Normal Cells
| Tetraspanin | Normal Function | HIV-1 Relevance |
|:------------|:----------------|:----------------|
| CD81 | Membrane organization, HCV entry | Viral assembly sites |
| CD82 | Metastasis suppression | Membrane domains |
| CD63 | Endosomal trafficking | Viral egress |
| CD9 | Cell fusion | Env incorporation |

### Consequences of Downregulation
| Effect | Mechanism |
|:-------|:----------|
| Altered membrane domains | Disrupted tetraspanin-enriched microdomains |
| Enhanced virus release | Reduced membrane rigidity |
| Immune evasion | Disrupted immunological synapse |

---

## NK Cell Evasion

### Ligand Modulation by Nef/Vpu
| Ligand | Normal Function | Modulation |
|:-------|:----------------|:-----------|
| MICA | NKG2D activation | Nef downregulation |
| MICB | NKG2D activation | Nef downregulation |
| ULBP1/2 | NKG2D activation | Variable |
| PVR (CD155) | DNAM-1 activation | Vpu downregulation |

### Evasion Strategy
> "By coordinately downregulating multiple activating ligands while sparing inhibitory ligands, HIV-1 creates an environment of net inhibition for NK cell recognition."

---

## Cooperative Actions of Nef and Vpu

### Division of Labor
| Function | Nef | Vpu | Overlap |
|:---------|:----|:----|:--------|
| CD4 downregulation | ✓ | ✓ | Complementary timing |
| Tetherin antagonism | Partial (SIV) | ✓ (HIV-1) | Species-specific |
| MHC-I modulation | ✓ | Limited | Nef primary |
| CD28 downregulation | ✓ | ✓ | Cooperative |

### Temporal Coordination
```
Early infection: Nef (immediate-early expression)
↓
Late infection: Vpu (late expression with Env)
↓
Continuous: Cooperative cell surface remodeling
```

---

## Quantitative Analysis

### Surface Receptor Reduction
| Receptor | % Reduction by Nef | % Reduction by Vpu |
|:---------|:-------------------|:-------------------|
| CD4 | 80-90% | 60-80% |
| MHC-I | 50-70% | <20% |
| Tetherin | <30% | 70-90% |
| CD28 | 40-60% | 30-50% |

---

## Therapeutic Implications

### Potential Intervention Points
| Target | Strategy | Challenge |
|:-------|:---------|:----------|
| Nef-AP complex | Disrupt interaction | Multiple adaptor binding sites |
| Vpu-tetherin | Block binding | Membrane protein interface |
| βTrCP recruitment | Inhibit E3 ligase | Host protein toxicity |
| Trafficking machinery | Block pathways | Essential cellular functions |

---

## Relevance to Project

Nef/Vpu receptor modulation research informs the Ternary VAE project:
- **Protein interaction domains**: Conserved binding motifs
- **Sequence-function mapping**: Critical residues for each target
- **Evolutionary constraints**: Maintaining multiple functions
- **Fitness trade-offs**: Balancing immune evasion vs replication
- **Drug target identification**: Interface residues for inhibition

---

*Added: 2025-12-24*
